GREEN LIFESCIENCE CO. LTD.

As of March 31, 2026, GREEN LIFESCIENCE CO. LTD. carries a market capitalization of 53.26B, placing it among publicly traded companies globally. Its enterprise value stands at 44.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, GREEN LIFESCIENCE CO. LTD. has 19.84M shares outstanding.

As of March 31, 2026, GREEN LIFESCIENCE CO. LTD. trades at a trailing price-to-earnings ratio of 17.19. The price-to-sales ratio is 1.01, and the price-to-book ratio stands at 1.33.

As of March 31, 2026, GREEN LIFESCIENCE CO. LTD. trades at an EV/EBITDA multiple of 16.39 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.88 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 22.83 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 44.95B versus a market cap of 53.26B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, GREEN LIFESCIENCE CO. LTD. maintains a current ratio of 2.17, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.13, indicating elevated leverage, while an interest coverage ratio of 11.97 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, GREEN LIFESCIENCE CO. LTD. posted a return on equity (ROE) of 8.07, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 4.62 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 5.97, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.60, useful for judging operating efficiency across full business cycles. The company generates approximately 784.87M in revenue per employee across its workforce of 65.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.42 indicates how many times GREEN LIFESCIENCE CO. LTD. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, GREEN LIFESCIENCE CO. LTD.'s stock has declined approximately 9.73% over the past 52 weeks. The 50-day moving average sits at 2,254.70, while the 200-day moving average is 2,529.38.

Over the twelve months ended March 31, 2026, GREEN LIFESCIENCE CO. LTD. generated 51.02B in revenue and converted that into 3.01B in net income, yielding earnings per share of 156.16. EBITDA reached 2.74B, while operating income came in at 1.97B.

As of March 31, 2026, GREEN LIFESCIENCE CO. LTD. holds 13.57B in cash and equivalents against 5.26B in total debt, resulting in a net debt position of -5.32B. Total book value stands at 40.04B, with working capital of 17.97B providing operational flexibility.

GREEN LIFESCIENCE CO. LTD. produced -1.94B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -1.40B in capital expenditures, free cash flow totaled -3.33B - equivalent to -172.98 per share.

Over the twelve months ended March 31, 2026, GREEN LIFESCIENCE CO. LTD. posted a gross margin of 8.22, reflecting its pricing power and cost economics. The operating margin of 3.86 and net profit margin of 5.90 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -6.44: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -4.21, meaning GREEN LIFESCIENCE CO. LTD. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

GREEN LIFESCIENCE CO. LTD.'s most recent stock split took place on September 5, 2023 with a 3:4 split ratio.

As of March 31, 2026, GREEN LIFESCIENCE CO. LTD. has an Altman Z-Score of 3.80, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.